SynSysNet: integration of experimental data on synaptic protein-protein interactions with drug-target relations

被引:33
|
作者
von Eichborn, Joachim [1 ]
Dunkel, Mathias [1 ]
Gohlke, Bjoern O. [1 ]
Preissner, Sarah C. [1 ]
Hoffmann, Michael F. [1 ]
Bauer, Jakob M. J. [1 ]
Armstrong, J. D. [2 ]
Schaefer, Martin H. [3 ]
Andrade-Navarro, Miguel A. [3 ]
Le Novere, Nicolas [4 ]
Croning, Michael D. R. [5 ,6 ]
Grant, Seth G. N. [5 ,6 ]
van Nierop, Pim [7 ]
Smit, August B. [7 ]
Preissner, Robert [1 ]
机构
[1] Charite, Inst Physiol, Struct Bioinformat Grp, D-13125 Berlin, Germany
[2] Sch Informat, Inst Neural Computat, Edinburgh EH8 9AB, Midlothian, Scotland
[3] Max Delbruck Ctr Mol Med, Computat Biol Grp, D-13125 Berlin, Germany
[4] Babraham Inst, Cambridge CB22 3AT, England
[5] Univ Edinburgh, Ctr Clin Brain Sci, Genes Cognit Programme, Edinburgh EH16 4SB, Midlothian, Scotland
[6] Univ Edinburgh, Ctr Neuroregenerat, Edinburgh EH16 4SB, Midlothian, Scotland
[7] Vrije Univ Amsterdam, Ctr Neurogen, Dept Mol & Cellular Neurobiol, NL-1081 HV Amsterdam, Netherlands
基金
英国生物技术与生命科学研究理事会;
关键词
DISEASES;
D O I
10.1093/nar/gks1040
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We created SynSysNet, available online at http://bioinformatics.charite.de/synsysnet, to provide a platform that creates a comprehensive 4D network of synaptic interactions. Neuronal synapses are fundamental structures linking nerve cells in the brain and they are responsible for neuronal communication and information processing. These processes are dynamically regulated by a network of proteins. New developments in interaction proteomics and yeast two-hybrid methods allow unbiased detection of interactors. The consolidation of data from different resources and methods is important to understand the relation to human behaviour and disease and to identify new therapeutic approaches. To this end, we established SynSysNet from a set of similar to 1000 synapse specific proteins, their structures and small-molecule interactions. For two-thirds of these, 3D structures are provided (from Protein Data Bank and homology modelling). Drug-target interactions for 750 approved drugs and 50 000 compounds, as well as 5000 experimentally validated protein-protein interactions, are included. The resulting interaction network and user-selected parts can be viewed interactively and exported in XGMML. Approximately 200 involved pathways can be explored regarding drug-target interactions. Homology-modelled structures are downloadable in Protein Data Bank format, and drugs are available as MOL-files. Protein-protein interactions and drug-target interactions can be viewed as networks; corresponding PubMed IDs or sources are given.
引用
收藏
页码:D834 / D840
页数:7
相关论文
共 50 条
  • [31] Databases of protein-protein interactions and their use in drug discovery
    Fuentes, Gloria
    Oyarzabal, Julen
    Rojas, Ana M.
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2009, 12 (03) : 358 - 366
  • [32] Protein Epitope Mimetics A new approach to target protein-protein interactions
    Gombert, Frank Otto
    Vrijbloed, Jan Willem
    Obrecht, Daniel
    UNDERSTANDING BIOLOGY USING PEPTIDES, 2006, : 178 - +
  • [33] Editorial: Protein-Protein Interactions: Drug Discovery for the Future
    Rapposelli, Simona
    Gaudio, Eugenio
    Bertozzi, Fabio
    Gul, Sheraz
    FRONTIERS IN CHEMISTRY, 2021, 9
  • [34] NMR as a tool to target protein-protein and protein-ligand interactions
    Lalli, D.
    De Pablo, R.
    Del Conte, R.
    Turano, P.
    FEBS JOURNAL, 2012, 279 : 437 - 437
  • [35] Triazabutadiene drug conjugates for the identification of protein-protein interactions
    Shepard, Abigail
    Jewett, John
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 255
  • [36] Identification of drug-target modules in the human protein–protein interaction network
    Hase T.
    Kikuchi K.
    Ghosh S.
    Kitano H.
    Tanaka H.
    Artificial Life and Robotics, 2014, 19 (04) : 406 - 413
  • [37] Computational Drug Design Targeting Protein-Protein Interactions
    Bienstock, Rachelle J.
    CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (09) : 1240 - 1254
  • [38] Structural biology and drug discovery for protein-protein interactions
    Jubb, Harry
    Higueruelo, Alicia P.
    Winter, Anja
    Blundell, Tom L.
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2012, 33 (05) : 241 - 248
  • [39] Motif mediated protein-protein interactions as drug targets
    Corbi-Verge, Carles
    Kim, Philip M.
    CELL COMMUNICATION AND SIGNALING, 2016, 14
  • [40] Integration of experimental data on gene expression and protein-protein lnteraction with predicted functional associations
    Brunak, S.
    MOLECULAR & CELLULAR PROTEOMICS, 2005, 4 (08) : S4 - S4